EMA Recommends Extension of Indications for Dostarlimab By Ogkologos - January 23, 2025 481 0 Facebook Twitter Google+ Pinterest WhatsApp Change concerns the first-line treatment of patients with endometrial cancer Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR ‘Inside Edition’ Anchor Thanks Viewer For Pointing Out Lump That Turned... April 24, 2019 What to Do When You Are Diagnosed With Cancer During Pregnancy January 19, 2021 Foodie Friday: Winter Warm-Up White Bean Soup February 11, 2022 Death Rates from Lung Cancer will Fall Overall in the EU... March 6, 2023 Load more HOT NEWS Activity of Targeted/Immune Therapy Approach in Patients with Advanced Urothelial Cancer Firefighter Advocates For Men’s Health While He Battles Breast Cancer In... Intratumoural and Intracavitary Administration of Ipilimumab Plus Nivolumab Is Feasible and... Tackling under-representation of Black data scientists in cancer research
